ACD/Labs Announces a New Partnership with the Center for Chemical Methodology and Library Development at Boston University (CMLD-BU)
Toronto, ON, Canada and Boston, MA, United States, August 29, 2005 -
Advanced Chemistry Development, Inc. (ACD/Labs) and the Center for Chemical Methodology and Library Development at Boston University (CMLD-BU) would like to announce that they have entered into a partnership to provide the CMLD-BU with a number of NMR-related software modules to aid them with structure confirmation, verification, and elucidation efforts. Some of the included modules are ACD/Labs' flagship computer-assisted structure elucidation package, ACD/Structure Elucidator, and ACD/Labs' high throughput NMR analysis software, ACD/CombiNMR.
ACD/Labs has a long standing commitment to helping academia by providing future scientists with access to the most current industry-standard software tools through unique academic software offerings and ongoing research partnerships.
Both ACD/Labs and the CMLD-BU believe that this partnership will be fruitful in helping the CMLD-BU achieve their three goals of creating novel chemical libraries, providing information about chemical methodologies, and collaborating with the biological community. Director of the CMLD-BU, Dr. John A. Porco, Jr. said recently, "The addition of ACD/Labs' software into our current workflow will dramatically decrease the data processing bottle neck we are currently experiencing in chemistry-driven structure elucidation projects and allow us to achieve our goals in a more timely manner."
About Advanced Chemistry Development
Advanced Chemistry Development, Inc., (ACD/Labs) is a chemistry software company offering solutions that truly integrate chemical structures with analytical chemistry information to produce ChemAnalytics®. ACD/Labs creates innovative software packages that aid chemical research scientists worldwide with spectroscopic validation of structures, elucidation of unknown substances, chromatographic separation, medicinal chemistry, preformulation of novel drug agents, systematic nomenclature generation, and chemical patenting and publication. Combined, ACD/Labs' solutions create an analytical informatics system that provides dramatic feed-forward effects on the chemical and pharmaceutical research process. Founded in 1993, and headquartered in Toronto, Canada, ACD/Labs employs a team of over 100 dedicated individuals whose continual efforts carry ACD/Labs' innovative technologies into pharmaceutical, biotech, chemical, and materials companies throughout the world. Information about Advanced Chemistry Development and its products can be found at www.acdlabs.com.
About the Chemical Methodology and Library Development Center at Boston University
The Center for Chemical Methodology and Library Development at Boston University (CMLD-BU), funded by the National Institute of General Medical Sciences (NIGMS), is focused on the discovery of new methodologies to produce novel chemical libraries of unprecedented complexity for biological screening. The goal of the CMLD-BU is to explore and expand the diversity of small-molecule libraries by creating general, useful protocols for stereocontrolled synthesis. This process involves the creation of novel chemical libraries that uniquely probe three-dimensional space by employing stereochemical and positional variation within the molecular framework as diversity elements for library design. A major objective of the CMLD-BU is also to provide information and chemistry protocols to the public on parallel and chemical library synthesis. The CMLD-BU has also organized the Chemical Library Consortium (CLC) to provide members of the biology community with access to its chemical libraries. The CLC will ultimately enable the demonstration of the quality of any given library through the identification of molecules that can be utilized as tools to investigate cellular processes.
|
